For Dog Owners
What is Arthritis?
Osteoarthritis (OA) is the most common form of arthritis and is present in 20% or 1 in 5 dogs over one year of age.
For Dog OwnersType at least two characters
Cartrophen Vet is a leading treatment for arthritis
View Our Products
Founded in the 1980s, Biopharm Australia is committed to furthering animal health through the best technology. Biopharm has been a world leader in osteoarthritis treatments for over 30 years.
Registered Countries
30
For Dog Owners
Osteoarthritis (OA) is the most common form of arthritis and is present in 20% or 1 in 5 dogs over one year of age.
For Dog OwnersFor Horse Owners
Osteoarthritis is the most common joint disease in horses and a survey suggested that 60% of lameness problems are related to OA.
For Horse OwnersFor Vets
Cartrophen Vet is a treatment for osteoarthritis and related musculoskeletal disorders in dogs and horses.
For VetsFor Scientists
Unique research for Biopharm Australia proving Cartrophen products significantly improve clinical signs of osteoarthritis and articular cartilage structure and function.
For ScientistsFounded in Australia in the 1980s, Biopharm Australia is a world leader in the research and development of sulfated polysaccharides for use in veterinary medicine and has ongoing research and development commitments in osteoarthritis, musculoskeletal diseases and cancer.
Biopharm Australia pioneered the veterinary development of sodium pentosan polysulfate as a disease modifying osteoarthritis drug (DMOAD) under the brand Cartrophen. The company invests heavily in the research and development of medicines that improve animal quality of life and strengthen the human-animal bond.
Our History

This is a prescribed veterinary medicine, veterinarians can contact the local distributor in their country for information on purchasing Cartrophen Vet.